SUBER Subcutaneous EEG Study
Subcutaneous EEG – Forecasting of Epileptic Seizures (SUBER) ClinicalTrials.gov Identifier: NCT04061707 Sponsor: King’s College London Funding Institution: Epilepsy Foundation Subcutaneous EEG – Forecasting of Epileptic Seizures (SUBER) is a 1-year observational study (n=10), where patients with refractory focal epilepsy will undergo ultra-longterm continuous recording of …
ART: Attention-Deficit/Hyperactivity
ADHD Remote Technology (ART) Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder that persists into adulthood in a significant proportion of individuals clinically diagnosed in childhood. The prevalence of ADHD among adults is 3-4% worldwide. The disorder is diagnosed based on impairing levels …
AIMS-2-TRIALS: Autism Remote Assessment Study
AIMS-2-TRIALS is a research programme that will investigate the biology of autism to tailor treatments and develop new therapies and medicines. AIMS-2-TRIALS stands for Autism Innovative Medicine Studies-2-Trials. It began in June 2018 and will run until May 2023. The research programme includes …
RADAR-CNS: Multiple Sclerosis
Multiple sclerosis (MS) is a condition in which the body’s immune system has an abnormal reaction to the central nervous system (CNS, made up of the brain, spinal cord and optic nerves). The immune system attacks elements of the CNS, disrupting the …
BigData@Heart – RATE-AF: Atrial Fibrillation
RATE-AF is an National Institute for Health Research (NIHR) funded study designed to compare two strategies of rate-control, based either on initial treatment with digoxin or beta-blockers in 160 patients with Atrial fibrillation (AF) in need for rate-control therapy. Monitoring with wearable …